XRP Ledger is now at the heart of a groundbreaking healthcare payment solution as Wellgistics Health Inc., a Nasdaq-listed pharmaceutical distributor, integrates blockchain technology to simplify transactions for pharmacies across the U.S.

Wellgistics Health Inc. unveiled plans to roll out a new blockchain-based payment infrastructure built on the XRP Ledger (XRPL). The company aims to streamline the way more than 6,500 independent pharmacies settle payments for their drug supply purchases. This innovative system significantly cuts delays and transaction fees often associated with traditional banking and credit card processing.

According to a recent announcement, the new platform enables real-time transfers, empowering pharmacies to instantly fund transactions for critical drug inventory. By eliminating intermediaries, Wellgistics is enhancing operational efficiency and cost-effectiveness within healthcare finance.

This blockchain-enabled system is deeply integrated with RxERP, an enterprise resource planning and e-commerce platform tailored for the pharmaceutical industry. The integration allows for seamless serialization of inventory, immediate settlement, and enhanced financial transparency. Interested pharmacies can already sign up for the beta version of the program.

The XRP Ledger, the underlying blockchain supporting this framework, is an open-source network known for fast, low-cost, and scalable transactions. While Ripple Labs leads XRPL’s core development, the ledger is used globally to support decentralized financial applications. The use of XRPL reflects Wellgistics’ strategy to modernize the healthcare finance industry through cutting-edge technology.

With over 200 pharmaceutical manufacturers already within its network, Wellgistics becomes one of the first major healthcare firms to leverage XRPL at such a broad scale. CEO Brian Norton noted that pharmacy owners are showing strong support for the initiative. He emphasized their openness to innovative financial tools, countering assumptions that the industry is slow to adopt blockchain technology.

The platform allows for invoice settlements via the XRP Ledger; however, the company has yet to clarify whether users will need to transact directly in XRP or if automatic fiat-to-XRP conversions will be utilized. Regardless, the system is structured to meet critical regulatory standards, including HIPAA for patient data protection and anti-money laundering protocols, ensuring both security and legal compliance.

Looking ahead, Wellgistics plans to broaden the blockchain payment system to include pharmaceutical manufacturers. The roadmap also includes testing direct-to-patient distribution models, enabling patients to receive medications directly from producers under the oversight of their doctors.

This initiative expands on a previous announcement made on May 8, where the company revealed its intentions to incorporate XRP not only as a transactional asset but as a part of its treasury strategy. Supported by a $50 million credit facility, this move aims to fuel liquidity on demand and support the financial infrastructure of Wellgistics’ expansive healthcare network.

Initially founded in 2016 as Wellgistics LLC, the firm was acquired by Danam Health in 2024. It later emerged as an independent public company via an IPO in February 2025. Today, as a standalone publicly traded entity, Wellgistics delivers wholesale distribution, prescription routing, and AI-driven support services to pharmacies nationwide.

Despite its innovative steps, the company’s stock performance has faced headwinds. Wellgistics shares are down over 80% since the IPO and recently closed at $0.62, although they edged up to $0.65 in after-hours trading. The firm’s current market capitalization stands around $47 million.

Related: XRP Price: $12M Max Pain for Bears

By embedding XRPL into its core financial operations and planning to hold XRP as a reserve asset, Wellgistics is establishing itself as both a champion and adopter of scalable blockchain solutions within the pharmaceutical logistics sphere.